Clinical trialNCT06667141RecruitingPhase 1Interventional

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

SponsorAcrivon TherapeuticsEnrollment100Specific Advanced Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Honorhealth Research Institute
Phoenix, Arizona, United States
Lyndsay Willmott, MD
Recruiting
Precision Nextgen Oncology & Research Center
Beverly Hills, California, United States
Kamlesh K Sankhala, MD
Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
Monica Mita, MD
Recruiting
Denver Health One
Denver, Colorado, United States
Gerald Falchook, MD
Recruiting
Florida Cancer Specialist
Sarasota, Florida, United States
Judy S Wang, MD
Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Gerburg Wulf, MD
Recruiting
University of Michigan
Ann Arbor, Michigan, United States
Zhen Ni Zhou, MD
Recruiting
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Katherine LaVigne Mager, MD
Recruiting
Montefiore Medical Centre
The Bronx, New York, United States
Nicole Nevadunsky, MD
Recruiting
Carolina Biooncology Institute
Huntersville, North Carolina, United States
Neel Gandhi, MD
Recruiting
Rhode Island Hospital
Providence, Rhode Island, United States
Benedito Carneiro, MD
Recruiting
Tennessee Oncology
Franklin, Tennessee, United States
Jeff Russell, MD
Recruiting
the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Timothy A Yap, MD,PhD
Recruiting
Next Oncology
San Antonio, Texas, United States
David Sommerhalder, MD
Recruiting
Next Virginia
Fairfax, Virginia, United States
Mohamad Salkeni, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Oct 2024
Primary completion: 12 Aug 2026
Completion: 12 Dec 2026
Last update posted: 23 Mar 2026
Registered enrollment: 100
Registry id: NCT06667141

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.